Optimizing End-To-End Safety In Clinical Development With Combined PV Solutions

This research report delves into the increasing significance of pharmacovigilance (PV) in clinical development, underscoring the need for robust and integrated PV systems to meet regulatory requirements and promote safety culture, with the help of advanced technologies for data storage, processing, and management.

As the PV operations in the life sciences industry evolve, a trend of outsourcing these operations is on the rise. The report reveals that two-thirds of life sciences organizations outsource PV operations, with vendor selection largely influenced by compliance. The outsourcing strategy is driven by the need to manage increasing volumes of data and the demand for specialized expertise and resources.

The challenges of outsourcing combined PV solutions are also highlighted in the report, such as financial constraints and miscommunication. It emphasizes the importance of establishing lasting relationships with vendors to mitigate these issues, as well as the potential cost savings and workflow optimization. The document further discusses the benefits and considerations of using combined PV solutions. It mentions the key barriers to outsourcing these services and technology, such as the risk of reliance on a single vendor, compliance risk, and data security issues.

Delve deeper into these aspects and what the future of PV services and technology in the life sciences industry could look like if innovation, regulatory vigilance, and collaboration with regulatory bodies were prioritized.